Sustained Continuous Glucose Monitor Use in Low-Income Youth with Type 1 Diabetes Following Insurance Coverage Supports Expansion of Continuous Glucose Monitor Coverage for All
Restricted accessLetterFirst published online September, 2018
Sustained Continuous Glucose Monitor Use in Low-Income Youth with Type 1 Diabetes Following Insurance Coverage Supports Expansion of Continuous Glucose Monitor Coverage for All
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care, 2010; 33:17–22.
2.
DanneT, NimriR, BattelinoT, et al.: International consensus on use of continuous glucose monitoring. Diabetes Care, 2017; 40:1631–1640.
3.
MillerKM, FosterNC, BeckRW, et al.: Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care, 2015; 38:971–978.
4.
De SalvoD, MillerKM, HermannJM, et al.: Continuous glucose monitoring (CGM) and glycemic control among youth with type 1 diabetes (T1D): international comparison from the T1D exchange and DPV initiative. Pediatr Diabetes, 2018; 1–5. DOI:10.1111/pedi.12711.
5.
WongJC, FosterNC, MaahsDM, et al.: Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care, 2014; 37:2702–2709.
6.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring StudyGroup, TamborlaneWV, BeckRW, et al.: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med, 2008; 359:1464–1476.
7.
TanenbaumML, AdamsRN, HanesSJ, et al.: Optimal use of diabetes devices: clinician perspectives on barriers and adherence to device use. J Diabetes Sci Technol, 2017; 11:484–492.
8.
JarowJP, LaVangeL, WoodcockJ: Multidimensional evidence generation and FDA regulatory decision making: defining and using “real-world” data. JAMA, 2017; 318:703–704.
9.
ClementsMA, FosterNC, MaahsDM, et al.: Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry. Pediatr Diabetes, 2016; 17:327–336.
10.
MillerKM, BeckRW, BergenstalRM, et al.: Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care, 2013; 36:2009–2014.
11.
PrahaladP, TanenbaumM, HoodK, MaahsDM: Diabetes technology: improving care, improving patient-reported outcomes and preventing complications in young people with type 1 diabetes. Diabet Med, 2018; 35:419–429.
12.
NaranjoD, TanenbaumML, IturraldeE, HoodKK: Diabetes technology: uptake, outcomes, barriers, and the intersection with distress. J Diabetes Sci Technol, 2016; 10:852–858.
13.
ChaseHP, BeckRW, XingD, et al.: Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Technol Ther, 2010; 12:507–515.
14.
GianiE, SnelgroveR, VolkeningLK, LaffelLM: Continuous glucose monitoring (CGM) adherence in youth with type 1 diabetes: associations with biomedical and psychosocial variables. J Diabetes Sci Technol, 2017; 11:476–483.
